SCISSORS · Single cell profiling of breast tumors and the residing immune cells leveraged by integration with multi-dimensional molecular data from thousands of tumors
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2021-01-01 → 2022-12-31
- Финансиране от ЕС
- 224 934 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Клетъчният състав на рака на гърдата и взаимодействието му с имунната система се анализират чрез сравнение на здрави и болни тъкани. Това помага за по-доброто разбиране на развитието на туморите и причините за тяхната устойчивост към терапията.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Single cell profiling of breast tumors and the residing immune cells leveraged by integration with multi-dimensional molecular data from thousands of tumors
Breast cancer is the most common type of cancer in Europe, responsible for the highest women cancer mortalities each year. Characterisation of breast tumours teased them apart to distinct subtypes and facilitated targeted treatments that improved survival rates significantly, yet some aggressive subtypes remain difficult to treat. New therapies that harness the patient own immune system to fight the tumour show remarkable success in several cancers but limited one in breast cancer. Single cell genomics methods that profile the tumour and its surrounding cells hold the potential to better understand the dynamics of tumour development and its resistance to therapy and improve current cancer treatment. The SCISSORS project aimed to profile normal and cancerous breast tissue samples on the single cell level to elucidate the interplay between genomic clones, their functional profile, and the response of the stromal environment as they all evolve. The objectives were 1) analyse a comprehensive single cell expression atlas of healthy human breast tissue, 2) develop a computational framework to infer somatic clones from single cell RNA-seq data, 3) profile the complete environment of normal and malignant breast tissues at single cell and clonal levels, and 4) extend results by integration with existing data on thousands of multi-dimensional molecularly profiled tumour samples. The technical developments made in the project facilitated the analysis of a large cohort of breast tumours from various types. Using a normal breast cell atlas as reference enabled the classification of single cells to phenotypes. We observed single cells mixing several normal epithelial breast phenotypes, a phenomenon confirmed to be unique to tumours. However, a minority of the tumours evaded this phenotypical plasticity and remained extremely homogenous. We were able to infer the genomic clones by combining several published and in-house tools. Integration of these genomic clones with the phenotypic classifications shed light on the dynamics of clonal evolution and the corresponding transcriptional changes.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Breast cancer is the most common type of cancer in Europe, responsible for the highest women cancer mortalities each year. Characterisation of breast tumours teased them apart to distinct subtypes and facilitated targeted treatments that improved survival rates significantly, yet some aggressive subtypes remain difficult to treat. New therapies that harness the patient own immune system to fight the tumour show remarkable success in several cancers but limited one in breast cancer. Single cell genomics is the cutting-edge method to profile tissues at the highest resolution. As a computational biologist experienced in this technique, I will use it to analyse breast tumours with their residing immune cells. I aim to dissect the dynamic processes that shape the clonal development of the tumour as it emerges from a healthy tissue, with an emphasis on the immune system response to the evolving tumour. Single cell genomics, being the main driving tool, will be leveraged by integration with vast data from thousands of deeply profiled tumour samples available in the Host lab. The project includes generation of a healthy breast single cell expression atlas; a computational method to infer somatic mutations clones from single cell genomics data; single cell profiling of breast tumours together with adjacent normal tissues; and lastly, integration of the results with data from the large tumours biobank that holds years of clinical history which may reveal new progression markers and improve risk stratification. This plan is unique by accounting for multiple aspects of the tumours, including normal to malignant transition, interplay of breast and immune cells, and tumour clonal dynamics. By tackling common cancer immune mechanisms, it may provide novel insights of relevance to all cancer types. Pursuing this grand project in a leading lab that covers all aspects of breast cancer research will increase my research versatility on my way to become an independent researcher.
Оригинален текст от CORDIS (на английски).
Участници
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE · CAMBRIDGEКоординаторОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
